OxyContin Maker’s Settlement Goes To Judge For Confirmation – InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Life Insurance
    • Annuity News
    • Health/Employee Benefits
    • Property and Casualty
    • Advisor News
    • Washington Wire
    • Regulation News
    • Sponsored Content
    • Webinars
    • Monthly Focus
  • INN Exclusives
  • NewsWires
  • Magazine
  • Free Newsletters
Sign in or register to be an INNsider.
  • INN Exclusives
  • NewsWires
  • Magazine
  • Free Newsletters
  • Insider
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Newsletters

Get Social

  • Facebook
  • Twitter
  • LinkedIn
Health Insurance Newsletter
Newswires RSS Get our newsletter
Order Prints
August 12, 2021 Newswires No comments
Share
Share
Tweet
Email

OxyContin Maker’s Settlement Goes To Judge For Confirmation

Associated Press

Purdue Pharma's quest to settle thousands of lawsuits over the toll of OxyContin and its other prescription opioid painkillers is entering its final phase with the grudging support of most of those who have claims against the company.

Nearly two years after seeking bankruptcy protection, the company is scheduled to appear before a U.S. Bankruptcy Court judge to ask for approval of its plan to reorganize into a new entity no longer controlled by members of the wealthy Sackler family, and with profits dedicated to abating the opioid crisis.

Opponents fault the deal for giving members of the Sackler family protection from lawsuits over opioids even though they have not personally filed for bankruptcy or admitted wrongdoing.

But most of the groups with claims against Purdue are on board with the settlement plan.

Ed Neiger, a lawyer representing individual victims and their families, is planning to tell U.S. Bankruptcy Court Judge Robert Drain that it's better to approve the settlement plan than to have years more of court battles with Purdue and the Sacklers.

“The plan must be analyzed in light of the alternative, not a comparison to the ideal,” Neiger said in an interview. “Five hundred thousand people have died as result of the opioid crisis thus far. If we go the all-out litigation route, another 500,000 might die before we see a penny from the Sacklers.”

Those with claims against Purdue were given a vote on the settlement, though Judge Drain is not bound by the results. Well over 90% of most groups of creditors — including local governments and individual victims — said they approved, according to court filings.

A group of Democratic state attorneys general were among the last to get on board. Until July, top state government lawyers were divided nearly evenly on whether to accept the deal. But several of the opponents signed on after Purdue agreed to make company records public and Sackler family members agreed to accelerate payments and increase payments. They would contribute a total of $4.5 billion in cash and a charitable fund.

An analysis commissioned by a group of state attorneys general before changes in the agreement found the wealth of Sackler family members, estimated at $10.7 billion in 2020, could rise to $14.6 billion by 2030 — even after the payments — because of investment returns and interest.

Sackler family members have been adamant that if they don't receive protections from lawsuits, they would not participate in the settlement and would instead mount a vigorous defense to any claims they face. One, David Sackler, a grandson of one of the three brothers who nearly 70 years ago bought the company that became Purdue, made a declaration in court and could be called to testify on it in the hearing.

“My family and I support the Shareholder Settlement because it represents an extraordinary opportunity to bring much needed resources to abate the opioid crisis, rather than spending years and depleting those resources defending the lawsuits against us,” he said in the statement.

Activist groups held a rally Monday outside the White Plains, New York, courthouse where Drain is based, urging him not to approve the deal.

“They are opioid profiteers who have caused mass death and they sit pretty in this court,” one of the activists, Megan Kapler, said at the protest. “And it's not right.”

The Purdue case is the highest-profile part of a vast landscape of litigation over an opioid epidemic that has been linked to more than 500,000 U.S. deaths since 2000, including those from prescription drugs such as OxyContin and generic painkillers, along with illicit drugs including heroin and illegally produced fentanyl.

In recent months, claims against other companies in the drug industry have gone to trial in California, New York and West Virginia, with more on tap in coming months. Some other firms are also settling. Drugmaker Johnson & Johnson and distribution companies AmerisourceBergen, Cardinal Health and McKesson are seeking state and local government acceptance of a deal worth $26 billion.

Purdue's case was separated from the others in 2019 when the company filed for the bankruptcy protection as it faced about 3,000 lawsuits from state and local governments, Native American tribes and others.

The company says its plan could be worth $10 billion over time. Profits and money already in the company's coffers would be used to abate the opioid crisis, funding treatment programs and education campaigns.

The value of the deal also includes the value of drugs Purdue is developing to reverse overdoses and inhibit addiction.

A portion of the money would also go to individual victims and their families. Payouts are expected to range from about $3,500 to $48,000.

Associated Press video journalist Ted Shaffrey in White Plains, New York, contributed to this report.

Older

N.H. Insurance Department Reminds Consumers That Health Insurance Marketplace Special Enrollment Ends August 15, 2021

Newer

Pa. Insurance Dept.: Wolf Administration Commemorates Pennie's Two-Year Anniversary

Advisor News

  • Here's one reason why America's racial wealth gap persists across generations
  • Ken Morris: Before you retire early, ask yourself a simple question
  • Half of Kansans have no retirement savings. This statewide program is a no-brainer
  • Savvy Senior: How to choose a 55-plus active adult community
  • Sinema took Wall Street money while killing tax on investors
More Advisor News

Annuity News

  • Colorado adopts new annuity sales regulations
  • National Western Life introduces new fixed indexed annuity, NWL New Frontiers
  • Jackson National announces second quarter 2022 results
  • Brighthouse Financial adds to Shield Level annuity suite with new product
  • Prudential FlexGuard reaches $10B total sales milestone at record pace
More Annuity News

Health/Employee Benefits News

  • EDITORIAL: Inflation Reduction Act is stealing Medicare dollars
  • UnitedHealthcare introduces new business unit Surest
  • Texas lawmakers ask feds to reconsider Medicaid expansion proposal
  • Plan to help poor Mississippians with health insurance stripped from latest federal bill
  • Giannis Antetokounmpo invests in telehealth company
More Health/Employee Benefits News

Life Insurance

  • Alex Murdaugh petitions to delay Mallory Beach trial amid murder charges
  • Sales of life combination products rebound in 2021, LIMRA reports
  • Integrity Marketing Group acquires Richman Insurance Agency
  • How to get the most out of Life Insurance Awareness Month
  • Life application activity down in July, MIB Index reports
More Life Insurance

- Presented By -

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

FEATURED OFFERS

Get Linked INN to your industry Connect with INN on LinkedIn to be first on all the news and insights that matter to your industry.

Press ReleasesAll press releases

  • National Western Life introduces newest fixed indexed annuity, NWL® New Frontiers
  • CybeReady Supports Security Defenses with CISO Toolkit
  • Life and Disability Income Insurance Products from MassMutual Now Available on iPipeline®’s End-to-End Digital Platform
  • Business on the Go with The Crump Mobile App
  • iPipeline® Provides Advisors Excel with Unified Path Toward Accessing Core Data Analytics in Financial Services
Add your Press Release >

Topics

  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty
  • Advisor News
  • Washington Wire
  • Regulation News
  • Sponsored Content
  • Webinars
  • Monthly Focus

Top Sections

  • Life Insurance
  • Annuity News
  • Health/Employee Benefits News
  • Property and Casualty News
  • AdvisorNews
  • Washington Wire
  • Insurance Webinars

Our Company

  • About
  • Editorial Staff
  • Magazine
  • Write for INN
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2022 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • AdvisorNews

Sign in with your INNsider Account

Not registered? Become an INNsider.